These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21996415)
1. Atorvastatin decreases lipoprotein(a): a meta-analysis of randomized trials. Takagi H; Umemoto T Int J Cardiol; 2012 Jan; 154(2):183-6. PubMed ID: 21996415 [No Abstract] [Full Text] [Related]
2. Elevated lipoprotein(a) with statin therapy. Spielberg T Am J Cardiol; 2000 May; 85(9):1162. PubMed ID: 10896622 [No Abstract] [Full Text] [Related]
3. Liptruzet: a combination of ezetimibe and atorvastatin. Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796 [No Abstract] [Full Text] [Related]
4. Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trial. Hernández C; Francisco G; Ciudin A; Chacón P; Montoro B; Llaverias G; Blanco-Vaca F; Simó R Diabetes Metab; 2011 Apr; 37(2):124-30. PubMed ID: 21131223 [TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease. Tekin A; Tekin G; Güzelsoy D; Kaya A; Gürel CV; Yiğit Z; Ulutin T Am J Cardiol; 2004 Jul; 94(2):206-9. PubMed ID: 15246903 [TBL] [Abstract][Full Text] [Related]
7. Atorvastatin: a new agent for hyperlipidemia. Kupecz D Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876 [No Abstract] [Full Text] [Related]
8. Intensive versus moderate lipid lowering with statins in acute coronary syndromes. Farmer JA Curr Atheroscler Rep; 2005 Mar; 7(2):85-6. PubMed ID: 15727720 [No Abstract] [Full Text] [Related]
9. Reversal of atherosclerosis with aggressive lipid lowering. Farmer JA Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721 [No Abstract] [Full Text] [Related]
10. A low-density lipoprotein-dependent effect of atorvastatin upon the systolic blood pressure reduction: meta-regression analyses of randomized trials. Takagi H; Umemoto T; Int J Cardiol; 2013 Dec; 170(1):e14-6. PubMed ID: 24169537 [No Abstract] [Full Text] [Related]
11. Atorvastatin and low-density lipoprotein subfractions profile in mixed hyperlipidaemia: a contributory effect of reduced hepatic lipase activity? Heller F; Descamps O; Hondekijn JC; Desager JP Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():788-9. PubMed ID: 10586326 [No Abstract] [Full Text] [Related]
12. Atorvastatin: in the management of hyperlipidaemia. Ray SK; Rege NN J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482 [No Abstract] [Full Text] [Related]
13. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too]. MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641 [No Abstract] [Full Text] [Related]
14. Atorvastatin in the management of an index patient with complete hepatic lipase deficiency. Hegele RA; Little JA; Connelly PW Atherosclerosis; 1999 Mar; 143(1):219-22. PubMed ID: 10208500 [No Abstract] [Full Text] [Related]
15. Atorvastatin--a new lipid-lowering drug. Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394 [No Abstract] [Full Text] [Related]
18. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering]. Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699 [No Abstract] [Full Text] [Related]
19. Routine statin treatment after acute coronary syndromes? Acevedo M; Sprecher DL; Lauer MS; Francis G Am Heart J; 2002 Jun; 143(6):940-2. PubMed ID: 12075242 [No Abstract] [Full Text] [Related]
20. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders]. Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894 [No Abstract] [Full Text] [Related] [Next] [New Search]